Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Elevated Blood Eosinophil Levels Predict Asthma Exacerbations

By Labmedica International staff writers
Posted on 05 Jun 2014
Print article
Image: Blood film showing five active eosinophils with a multisegmented nucleus and numerous eosinophilic granules (Photo courtesy of American Academy of Pediatrics).
Image: Blood film showing five active eosinophils with a multisegmented nucleus and numerous eosinophilic granules (Photo courtesy of American Academy of Pediatrics).
In adults with persistent asthma, elevated blood eosinophil levels may be able to predict which individuals are at increased risk for exacerbations.

Eosinophils are white blood cells that become active in individuals with certain allergic diseases, including asthma, and other medical conditions such as parasitic infections.

Physicians at Kaiser Permanente (San Diego, CA, USA) measured blood eosinophil level in 2,392 adult asthma patients in 2010 and the relationship between these levels and the rate of exacerbations in 2011 was determined in analyses adjusting for demographics, comorbidities, and asthma burden and care.

The scientists found that increasing level of blood eosinophil at baseline was associated with increasing risk of future asthma exacerbation in both crude and adjusted analyses. The relationship was observed in crude analysis for baseline eosinophil level of greater than 300/mm3 with crude rate ratio 1.25, but was weaker after adjustment for baseline characteristics with an adjusted rate ratio 1.16.

In 2011, after adjustment for baseline features, the adjusted rate ratio of 1.31, which was highly significant, the authors concluded that a baseline eosinophil level of greater than 400/mm3 was associated with future asthma exacerbations. Other factors in 2010 that were significantly associated with an increased risk of exacerbations in 2011 included a history of prior asthma exacerbations, Global Initiative for Asthma (GINA) steps-4/5, dispensing of seven or more short-acting beta-agonist canisters, female gender, black ethnicity, and obesity.

Robert S. Zeiger, MD, PhD, the Physician Investigator at Kaiser Permanente, said, “Eosinophils are known to be involved in the pathophysiology of asthma, and determining their relationship with asthma exacerbations may allow us to determine in advance which of these patients needs targeted interventions. In our study, elevated blood eosinophil levels were found to be a risk factor for subsequent exacerbations in adult asthma patients”.

Dr. Zeiger added “Our findings suggest that asthma patients with an elevated blood eosinophil level have a greater disease burden. If our findings can be replicated in other populations and settings, measurement of blood eosinophil levels may help guide treatment for patients at the greatest risk for exacerbations.” The study was presented at the American Thoracic Society International Conference, held May 16–21, 2014, in San Diego (CA, USA).

Related Links:

Kaiser Permanente




Print article

Channels

Clinical Chemistry

view channel

New Approach Improves Identification of Women at High Risk of Preeclampsia

A new meta-analysis examining 92 cohort studies involving over 25 million pregnancies has provided an unprecedented understanding of risk factors for preeclampsia—some risk factors being strong enough to warrant that a pregnant woman starts on prophylactic treatment with acetylsalicylic acid (ASA) when she has only one.... Read more

Genetic Tests

view channel

Patterns of MicroRNA Expression Distinguish Patients with Asthma and Allergic Rhinitis

Subsets of circulating micro RNAs (miRNAs) are uniquely expressed in asthmatic patients and in patients with allergic rhinitis (AR) and have potential for use as noninvasive biomarkers to diagnose and characterize these diseases. MicroRNAs are a class of about 20 nucleotides-long RNA fragments that block gene expression... Read more

Pathology

view channel

Liver Cancer May Be Diagnosed from Altered Sugar Metabolism

Altered gene expression that causes cancerous cells to metabolize fructose differently from healthy cells could be a significant new biomarker for diagnosing liver cancer. Dietary fructose is primarily metabolized in the liver and it has now been demonstrated that, compared with normal hepatocytes, hepatocellular carcinoma... Read more

Lab Tech.

view channel

Method Preserves Microfluidic Devices for HIV Monitoring in Developing Countries

Microfluidic devices with immunochemistry have broad applications in chemotherapy monitoring, transplant patient monitoring, and especially in monitoring the efficacy of antiretroviral therapy. Providing vital health care services to people in developing countries without reliable electricity, refrigeration and state-of-the-art... Read more

Industry News

view channel

R-Biopharm and Merck Partner on Companion Diagnostics

R-Biopharm AG (Darmstadt, Germany) and Merck KGaA (Darmstadt, Germany) have entered into an agreement that constitutes their first collaboration, which will initially focus on developing and launching companion diagnostics. Companion diagnostics play a central role in personalized medicine by helping to find specific... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.